Global DNA Methylation Detection Technology Market Analysis 2023-2024 & 2023: Increasing Adoption as Epigenetic Biomarkers, Bisulfite Conversion as a Gold Standard, R&D in Genomics/Epigenetics
March 29, 2024 05:34 ET
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Global DNA Methylation Detection Technology Market: Focus on Technology, Application, End User, Product Type, Country Level Analysis and Competitive...
Global Molecular Cytogenetics Market Forecast to Reach $3.39 Billion by 2029, Driven by Innovations in Oncology Diagnostics and Personalized Medicine
March 27, 2024 08:13 ET
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Molecular Cytogenetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters
March 25, 2024 08:02 ET
|
TeleDaas PLLC
TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters
Transfection Technologies Market to Reach $1.8 Billion by 2028, Driven by Advances and Growing Demand for Therapeutic Delivery
March 22, 2024 05:05 ET
|
Research and Markets
Dublin, March 22, 2024 (GLOBE NEWSWIRE) -- The "Global Transfection Technologies Market by Product (Kits, Equipment), Method (Physical (Electroporation, Microinjection), Biochemical (Lipofection,...
Precision Medicine Market Deal Making Trends: "Precision Medicine Collaboration and Licensing Deals (2016-2023)" Comprehensive Report Released
March 18, 2024 05:39 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering. The realm of precision...
Bayer and Aignostics to collaborate on next generation precision oncology
March 14, 2024 03:30 ET
|
Aignostics GmbH
Not intended for UK Media Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development, further strengthening Bayer’s...
Global gRNA Research Analysis Report 2024: Precision in Gene Editing and Rising Adoption of NGS Technologies Enhancing gRNA Applications
March 13, 2024 11:55 ET
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global gRNA Market Size, Share & Trends Analysis Report by Product & Services (Products, Custom gRNA Synthesis Services), gRNA Type...
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2023
March 07, 2024 14:59 ET
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.Precision...
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
March 07, 2024 12:07 ET
|
SOPHiA GENETICS, Inc.
BOSTON and ROLLE, Switzerland, March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Chief...
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
March 06, 2024 09:15 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...